Tetralogic Pharmaceuticals Corp Stock Fundamentals
TetraLogic Pharmaceuticals Corp fundamentals help investors to digest information that contributes to TetraLogic Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of TetraLogic Pink Sheet. The fundamental analysis module provides a way to measure TetraLogic Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TetraLogic Pharmaceuticals pink sheet.
TetraLogic |
TetraLogic Pharmaceuticals Corp Company Return On Asset Analysis
TetraLogic Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current TetraLogic Pharmaceuticals Return On Asset | -0.2 |
Most of TetraLogic Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, TetraLogic Pharmaceuticals Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, TetraLogic Pharmaceuticals Corp has a Return On Asset of -0.1959. This is 97.76% lower than that of the Biotechnology sector and 99.17% lower than that of the Health Care industry. The return on asset for all United States stocks is 39.93% higher than that of the company.
TetraLogic Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TetraLogic Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare TetraLogic Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TetraLogic Pharmaceuticals competition to find correlations between indicators driving TetraLogic Pharmaceuticals's intrinsic value. More Info.TetraLogic Pharmaceuticals Corp is currently regarded as top stock in return on asset category among its peers. It also is currently regarded number one company in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TetraLogic Pharmaceuticals' earnings, one of the primary drivers of an investment's value.TetraLogic Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TetraLogic Pharmaceuticals' direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of TetraLogic Pharmaceuticals could also be used in its relative valuation, which is a method of valuing TetraLogic Pharmaceuticals by comparing valuation metrics of similar companies.TetraLogic Pharmaceuticals is currently under evaluation in return on asset category among its peers.
TetraLogic Fundamentals
| Return On Asset | -0.2 | ||||
| Current Valuation | 458.72 K | ||||
| Shares Outstanding | 24.47 M | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 1.18 M | ||||
| Price To Earning | (0.03) X | ||||
| Price To Book | 0.40 X | ||||
| EBITDA | (43.15 M) | ||||
| Net Income | (49.72 M) | ||||
| Cash And Equivalents | 5.89 M | ||||
| Cash Per Share | 0.24 X | ||||
| Total Debt | 28.33 M | ||||
| Debt To Equity | 4.17 % | ||||
| Current Ratio | 0.48 X | ||||
| Book Value Per Share | (1.25) X | ||||
| Cash Flow From Operations | (34.89 M) | ||||
| Short Ratio | 4.39 X | ||||
| Earnings Per Share | (1.65) X | ||||
| Target Price | 1.0 | ||||
| Number Of Employees | 29 | ||||
| Beta | 3.0 | ||||
| Market Capitalization | 229.36 K | ||||
| Total Asset | 64.02 M | ||||
| Retained Earnings | (175.56 M) | ||||
| Working Capital | 18.31 M | ||||
| Current Asset | 21.97 M | ||||
| Current Liabilities | 3.66 M | ||||
| Z Score | -2.8 | ||||
| Net Asset | 64.02 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in TetraLogic Pink Sheet
If you are still planning to invest in TetraLogic Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TetraLogic Pharmaceuticals' history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |